IT1294967B1 - Composizione immunogenica da tlp - Google Patents

Composizione immunogenica da tlp

Info

Publication number
IT1294967B1
IT1294967B1 IT96RM000687A ITRM960687A IT1294967B1 IT 1294967 B1 IT1294967 B1 IT 1294967B1 IT 96RM000687 A IT96RM000687 A IT 96RM000687A IT RM960687 A ITRM960687 A IT RM960687A IT 1294967 B1 IT1294967 B1 IT 1294967B1
Authority
IT
Italy
Prior art keywords
seq
tlp
immunogenic composition
uro
peptides
Prior art date
Application number
IT96RM000687A
Other languages
English (en)
Inventor
Giulio Tarro
Original Assignee
Ist Farmacoterapico It Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT96RM000687A priority Critical patent/IT1294967B1/it
Application filed by Ist Farmacoterapico It Spa filed Critical Ist Farmacoterapico It Spa
Priority to ES97945086T priority patent/ES2138574T3/es
Priority to EP97945086A priority patent/EP0938329B1/en
Priority to PCT/IT1997/000240 priority patent/WO1998015282A1/en
Priority to JP51736198A priority patent/JP2001508764A/ja
Priority to DE69712907T priority patent/DE69712907T2/de
Priority to PT97945086T priority patent/PT938329E/pt
Priority to CN97180260A priority patent/CN1239431A/zh
Priority to DK97945086T priority patent/DK0938329T3/da
Priority to IL12936897A priority patent/IL129368A0/xx
Priority to KR1019990703053A priority patent/KR20000048995A/ko
Priority to DE0938329T priority patent/DE938329T1/de
Priority to RU98112608/14A priority patent/RU2192274C2/ru
Priority to US09/284,051 priority patent/US20020031531A1/en
Priority to AT97945086T priority patent/ATE218064T1/de
Priority to AU46376/97A priority patent/AU725218B2/en
Priority to CA002267905A priority patent/CA2267905A1/en
Publication of ITRM960687A1 publication Critical patent/ITRM960687A1/it
Priority to NO991653A priority patent/NO991653L/no
Application granted granted Critical
Publication of IT1294967B1 publication Critical patent/IT1294967B1/it
Priority to US10/631,838 priority patent/US20040022870A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/86—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/892—Reproductive system [uterus, ovaries, cervix, testes]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/55—Lung
IT96RM000687A 1996-10-09 1996-10-09 Composizione immunogenica da tlp IT1294967B1 (it)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT96RM000687A IT1294967B1 (it) 1996-10-09 1996-10-09 Composizione immunogenica da tlp
RU98112608/14A RU2192274C2 (ru) 1996-10-09 1997-10-09 Иммуногенная композиция на основе tlp
PCT/IT1997/000240 WO1998015282A1 (en) 1996-10-09 1997-10-09 Immunogenic tlp composition
JP51736198A JP2001508764A (ja) 1996-10-09 1997-10-09 免疫原性ｔｌｐ組成物
DE69712907T DE69712907T2 (de) 1996-10-09 1997-10-09 Immunogene tlp-zusammensetzung
PT97945086T PT938329E (pt) 1996-10-09 1997-10-09 Composicao de tlp imunogenica
CN97180260A CN1239431A (zh) 1996-10-09 1997-10-09 致免疫的tlp组合物
DK97945086T DK0938329T3 (da) 1996-10-09 1997-10-09 Immunogen TLP sammensætning
ES97945086T ES2138574T3 (es) 1996-10-09 1997-10-09 Composicion inmunogenica a base de particulas liberadas por el tumor.
KR1019990703053A KR20000048995A (ko) 1996-10-09 1997-10-09 면역원 ｔｌｐ 조성물
DE0938329T DE938329T1 (de) 1996-10-09 1997-10-09 Immunogene tlp-zusammensetzung
EP97945086A EP0938329B1 (en) 1996-10-09 1997-10-09 Immunogenic tlp composition
US09/284,051 US20020031531A1 (en) 1996-10-09 1997-10-09 Immunogenic tlp composition
AT97945086T ATE218064T1 (de) 1996-10-09 1997-10-09 Immunogene tlp-zusammensetzung
AU46376/97A AU725218B2 (en) 1996-10-09 1997-10-09 Immunogenic TLP composition
CA002267905A CA2267905A1 (en) 1996-10-09 1997-10-09 Immunogenic tlp composition
IL12936897A IL129368A0 (en) 1996-10-09 1997-10-09 Immunogenic TLP composition
NO991653A NO991653L (no) 1996-10-09 1999-04-08 Immunogenisk tumor frigjorte partikler (TLP)-blanding
US10/631,838 US20040022870A1 (en) 1996-10-09 2003-07-31 Immunogenic TLP composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000687A IT1294967B1 (it) 1996-10-09 1996-10-09 Composizione immunogenica da tlp

Publications (2)

Publication Number Publication Date
ITRM960687A1 ITRM960687A1 (it) 1998-04-09
IT1294967B1 true IT1294967B1 (it) 1999-04-23

Family

ID=11404462

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96RM000687A IT1294967B1 (it) 1996-10-09 1996-10-09 Composizione immunogenica da tlp

Country Status (17)

Country Link
US (2) US20020031531A1 (it)
EP (1) EP0938329B1 (it)
JP (1) JP2001508764A (it)
KR (1) KR20000048995A (it)
CN (1) CN1239431A (it)
AT (1) ATE218064T1 (it)
AU (1) AU725218B2 (it)
CA (1) CA2267905A1 (it)
DE (2) DE69712907T2 (it)
DK (1) DK0938329T3 (it)
ES (1) ES2138574T3 (it)
IL (1) IL129368A0 (it)
IT (1) IT1294967B1 (it)
NO (1) NO991653L (it)
PT (1) PT938329E (it)
RU (1) RU2192274C2 (it)
WO (1) WO1998015282A1 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317853B1 (it) * 2000-02-25 2003-07-15 Unihart Corp Peptidi tlp e sequenze di dna che li codificano.
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
CA2593086A1 (en) 2004-12-30 2006-07-06 Vito Michele Fazio Anti-tumoral immunogenic peptides and vaccine thereof
JP2011507862A (ja) * 2007-12-21 2011-03-10 コーダ セラピューティクス， インコーポレイテッド 異常瘢痕または過剰瘢痕の治療のための抗コネキシン４３ポリヌクレオチドの使用
ITRM20100256A1 (it) * 2010-05-19 2011-11-20 Farmafin Spa Un nuovo biomarcatore per la diagnosi precoce e l'immunoterapia del cancro
EP3167898A1 (en) 2015-11-11 2017-05-17 IEO - Istituto Europeo di Oncologia Srl Method for obtaining tumor peptides and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206250B (it) * 1987-02-18 1989-04-14 Ist Farmacoterapico It Spa Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla-
IT1262954B (it) * 1992-07-03 1996-07-23 Ist Farmacoterapico It Spa Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.

Also Published As

Publication number Publication date
DE69712907D1 (de) 2002-07-04
ATE218064T1 (de) 2002-06-15
US20020031531A1 (en) 2002-03-14
RU2192274C2 (ru) 2002-11-10
DK0938329T3 (da) 2002-09-09
ITRM960687A1 (it) 1998-04-09
PT938329E (pt) 2002-10-31
US20040022870A1 (en) 2004-02-05
JP2001508764A (ja) 2001-07-03
WO1998015282A1 (en) 1998-04-16
EP0938329A1 (en) 1999-09-01
NO991653D0 (no) 1999-04-08
AU725218B2 (en) 2000-10-05
KR20000048995A (ko) 2000-07-25
ES2138574T1 (es) 2000-01-16
EP0938329B1 (en) 2002-05-29
DE69712907T2 (de) 2002-12-12
NO991653L (no) 1999-06-08
IL129368A0 (en) 2000-02-17
AU4637697A (en) 1998-05-05
CN1239431A (zh) 1999-12-22
CA2267905A1 (en) 1998-04-16
ES2138574T3 (es) 2002-11-01
DE938329T1 (de) 2000-04-06

Similar Documents

Publication Publication Date Title
HK1021824A1 (en) Compositions and methods for treating infections using analogues of indolicidin
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
EP2258383A3 (en) Antigenic peptides derived from telomerase
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
ATE306931T1 (de) Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
HK1026144A1 (en) Aryl ureas for the treatment of inflammatory or immunomodulatory diseases.
DE69922822D1 (de) Rekombinante haarbehandlungsmittel
EP1918300A3 (en) Peptide-based immunization therapy for treatment of atherosclerosis
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
EP1071443A4 (en) ISOLATED PEPTIDES CORRESPOND THE NY-ESO-1 AMINO ACID SEQUENCES AND BIND TO MHC CLASS I AND MHC CLASS II MOLECULES AND THEIR USE
DE69420145T2 (de) Behandlung präkanzeröser läsionen durch muramylpeptide
IT1294967B1 (it) Composizione immunogenica da tlp
DE3584775D1 (de) Zusammensetzung zur behandlung von an haemophilia-a-inhibitor leidenden kranken.
DE69941877D1 (de) Neovaskular-spezifische peptide
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
PT782630E (pt) Gene da doenca poliquistica do rim
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
NO20011263L (no) Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
WO2004089980A3 (en) Therapeutic cancer vaccine

Legal Events

Date Code Title Description
0001 Granted